CORONA - Parmenides - DIRECT-Dx - TP1
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:1 publications
Grant number: 03COV24A
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$834,998.11Funder
Federal Ministry of Research, Technology and Space (BMFTR)Principal Investigator
Frank BierResearch Location
GermanyLead Research Institution
Universität PotsdamResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Within the framework of the joint project "DIRECT-Dx", antibodies directed against the SARS-CoV-2 virus are to be developed, which will serve as the basis for a new rapid test procedure. Compared to other diagnostics, such antibody-based direct detections indicate the intact and therefore infectious virus. With the aid of this test procedure, the alliance hopes to create an effective means of rapidly detecting any infections and thus isolating sources of infection at an early stage. A simple detection system, e.g. in the form of a color change or a strip test, is to be developed. In addition to simple handling, such an antibody-based detection method also offers the possibility of obtaining timely on-site results.
1 Publication linked via Europe PMC
Last Updated:4 days ago
View all publications at Europe PMC